Skip to main content

Coen Steven P.'s Form 4 filing

Ginkgo Bioworks Holdings, Inc.DNA · filed Jul 20, 2026

Accession no.
0001628280-26-048832
Filed
Jul 20, 2026, 5:00 PM ET
Trade date
Jul 16-17, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $5.94K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Coen Steven P.CIK 0001977441Officer (See remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 16, 2026Class A Common StockMOption exerciseAcquired+1,174–F1–51,878Direct
Jul 16, 2026Class A Common StockMOption exerciseAcquired+312–F1–52,190Direct
Jul 17, 2026Class A Common StockSSaleDisposed−752$7.90−$5,943.0651,438Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 16, 2026Class A Common StockMOption exerciseDisposed−1,174–F1–5,883Direct
Jul 16, 2026Class A Common StockMOption exerciseDisposed−312–F1–3,131Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

Remarks

Chief Financial Officer

Read the full filing on SEC EDGAR (opens in a new tab)